Since launching in February of this year, BMC Research Notes has quickly become one of the top 10 journals in the BMC series in terms of the manuscripts we receive and now, just eight months after its launch, a paper by Eilebrecht, Pellay and colleagues entitled “EBER2 RNA-induced transcriptome changes identify cellular processes likely targeted during Epstein Barr Virus infection” is our 100th published article. We are very pleased with this milestone and the notable submissions we are continuing to receive.
This Short Report discusses Epstein-Barr Virus (EBV)-encoding RNAs (EBERs), which are strongly expressed in EBV-infected cells and are reliable diagnostic markers for EBV, but whose role remains elusive. Two groups from L’Institut des Hautes Études Scientifiques and Ruhr University Bochum investigated the roles and targets of EBER2 and their results indicate a potential role of EBER2 in regulating the activity of cellular pathways related to growth and the cytoskeleton and in immune responses and cellular stress. This study provides a novel avenue to the identification of EBER2 targets and the understanding of the physiology of EBV.
The goal of BMC Research Notes is to provide a home for short publications like our 100th article, as well as case series, updates to previous work, results of individual experiments and similar material that currently lacks a suitable outlet. The intention of BMC Research Notes is to reduce the loss suffered by the research community when such results remain unpublished.
We expect that the reputation of BMC Research Notes will continue to rise and attract the submission of these valuable manuscripts that otherwise may have remained unpublished.
For more information about BMC Research Notes please visit our website at www.biomedcentral.com/bmcresnotes/
BMC Research Notes